PYK2 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

55 results for “PYK2”

Trials

TYK2 Inhibition in Paradoxical Psoriasis

2 participants · First posted Feb 28, 2024

Active, not recruiting

Vitiligo Treatment by Targeting TYK2 Mediated Responses

128 participants · First posted Mar 25, 2024

Dual JAK1/TYK2 Inhibitor for Cicatricial Alopecia

50 participants · First posted Oct 13, 2021

Drugs

View all 12 →

TYK2 inhibitor

CN-PYB2

TYK2 inhibitors (Cullgen)

News

View all 35 →

Verastem Oncology's RAMP 203 Trial Shows Encouraging Initial Data for Triplet Combination in Advanced KRAS G12C Mutant NSCLC

Dual Drug Combinations Show Promise in Overcoming Multiple Myeloma Resistance

Verastem Oncology to Present New LGSOC Treatment Data at SGO 2025 Annual Meeting

Page 1 of 6